Prevalence and Prognostic Impact of Hyponatremia in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Retrospective Observational Study

Jofin George; Uday C Kakodkar; Nikita S Talaulikar

doi:10.55489/njmr.150420251167

Authors

Jofin George Department of Respiratory Medicine, Goa Medical College, Bambolim, Goa, India
Uday C Kakodkar Department of Respiratory Medicine, Goa Medical College, Bambolim, Goa, India
Nikita S Talaulikar Department of Respiratory Medicine, Goa Medical College, Bambolim, Goa, India

DOI:

https://doi.org/10.55489/njmr.150420251167

Keywords:

Chronic obstructive pulmonary disease, hyponatremia, length of stay, prognosis

Abstract

Background: Few studies determine the prevalence and clinical progress of hospitalized patients having hyponatremia with COPD exacerbation. The objectives were to determine the prevalence of hyponatremia in hospitalized patients of COPD exacerbation, and compare the clinical and laboratory parameters in these patients.

Methodology: Retrospective observational study was carried out among 200 patients admitted with COPD exacerbation over a period of three months from October to December 2024. Patients of CKD, CLD, acute cardiac events, hypernatremia and deaths were excluded. Hyponatremia was defined as serum sodium <136mmol/L. Poor progress was defined as prolonged stay (>8 days), or readmission within one month of previous hospitalization.

Results: 112(56%) cases had hyponatremia (128.98±5.85 vs 138.88±2.22 mmol/L, 95%CI: t=16.45, p<0.001). Patients with hyponatremia were older (71.68±8.093 vs 68.8±7.645 years, 95%CI: t=2.562, p=0.011), had longer hospital stay (11.77±7.263 vs 7.24±2.849 days, 95%CI: t=6.035, p<0.001), lower albumin (95%CI: t=2.798, p=0.006), and a higher chance of being mechanically ventilated (OR=2.39, 95%CI: 1.34-4.22, p=0.003). Patients developing hospital acquired infection were more likely to develop hyponatremia (OR=18.9, 95%CI: 2.48-144, p<0.001). Hyponatraemic patients had poorer progress (OR=4.83, 95%CI: 2.64-8.84, p<0.001) and higher readmission rates (OR=6.07, 95%CI: 2.25-16.4, p<0.001).

Conclusions: Patients of COPD exacerbation have high prevalence of hyponatremia which requires early detection, routine screening, and monitoring for clinical deterioration.

References

Hawkins RC. Age and gender as risk factors for hyponatremia and hypernatremia. Clin Chim Acta. 2003 Nov;337(1-2):169-172. DOI: https://doi.org/10.1016/j.cccn.2003.08.001 PMid:14568195 DOI: https://doi.org/10.1016/j.cccn.2003.08.001

Lindner G, Herschmann S, Funk GC, Exadaktylos AK, Gygli R, Ravioli S. Sodium and potassium disorders in patients with COPD exacerbation presenting to the emergency department. BMC Emerg Med. 2022 Mar 24;22(1):49. DOI: https://doi.org/10.1186/s12873-022-00607-7 PMid:35331155 PMCid:PMC8943967 DOI: https://doi.org/10.1186/s12873-022-00607-7

Tokgöz Akyıl F, Tural Önür S, Abalı H, Sökücü S, Özdemir C, Boyracı N, Kocaoğlu A, Altın S. Hyponatremia is an independent predictor of emergency department revisits in acute exacerbation of COPD. Clin Respir J. 2021 Oct;15(10):1063-1072. DOI: https://doi.org/10.1111/crj.13409 PMid:34097800 DOI: https://doi.org/10.1111/crj.13409

Chalela R, González-García JG, Chillarón JJ, Valera-Hernández L, Montoya-Rangel C, Badenes D, Mojal S, Gea J. Impact of hyponatremia on mortality and morbidity in patients with COPD exacerbations. Respir Med. 2016 Aug;117:237-242. DOI: https://doi.org/10.1016/j.rmed.2016.05.003 PMid:27492537 DOI: https://doi.org/10.1016/j.rmed.2016.05.003

García-Sanz MT, Martínez-Gestoso S, Calvo-Álvarez U, Doval-Oubiña L, Camba-Matos S, Rábade-Castedo C, Rodríguez-García C, González-Barcala FJ. Impact of Hyponatremia on COPD Exacerbation Prognosis. J Clin Med. 2020 Feb 12;9(2):503. DOI: https://doi.org/10.3390/jcm9020503 PMid:32059573 PMCid:PMC7074146 DOI: https://doi.org/10.3390/jcm9020503

Mohan S, Gu S, Parikh A, Radhakrishnan J. Prevalence of hyponatremia and association with mortality: results from NHANES. Am J Med. 2013 Dec;126(12):1127-37.e1. DOI: https://doi.org/10.1016/j.amjmed.2013.07.021 PMid:24262726 PMCid:PMC3933395 DOI: https://doi.org/10.1016/j.amjmed.2013.07.021

Kwok WC, Yap DYH, Tam TCC, Lam DCL, Ip MS, Ho JCM. Impact of Hyponatraemia at Clinical Stable-State on Survival in Patients with Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2025 Jan 15;20:127-135. DOI: https://doi.org/10.2147/COPD.S488309 PMid:39830625 PMCid:PMC11742628 DOI: https://doi.org/10.2147/COPD.S488309

Global Initiative for Chronic Obstructive Lung Disease, Inc. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2025 Report). GOLD; 2025. Available from: https://goldcopd.org/wp-content/uploads/2024/11/GOLD-2025-Report-v1.0-15Nov2024_WMV.pdf [Accessed on Aug 30, 2025]

World Health Organization. Chronic obstructive pulmonary disease (COPD); 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).

Hlapčić I, Belamarić D, Bosnar M, et al. Combination of Systemic Inflammatory Biomarkers in Assessment of Chronic Obstructive Pulmonary Disease: Diagnostic Performance and Identification of Networks and Clusters. Diagnostics (Basel). 2020 Nov 30;10(12):1029. DOI: https://doi.org/10.3390/diagnostics10121029 PMid:33266187 PMCid:PMC7760570 DOI: https://doi.org/10.3390/diagnostics10121029

Park SJ, Shin JI. Inflammation and hyponatremia: an underrecognized condition? Korean J Pediatr. 2013 Dec;56(12):519-522. DOI: https://doi.org/10.3345/kjp.2013.56.12.519 PMid:24416046 PMCid:PMC3885786 DOI: https://doi.org/10.3345/kjp.2013.56.12.519

Rodriguez M, Hernandez M, Cheungpasitporn W, et al. Hyponatremia in Heart Failure: Pathogenesis and Management. Curr Cardiol Rev. 2019;15(4):252-261. DOI: https://doi.org/10.2174/1573403X15666190306111812 PMid:30843491 PMCid:PMC8142352 DOI: https://doi.org/10.2174/1573403X15666190306111812

Sumi H, Tominaga N, Fujita Y, Verbalis JG; and the Electrolyte Winter Seminar, Collaborative Group. Pathophysiology, symptoms, outcomes, and evaluation of hyponatremia: comprehension and best clinical practice. Clin Exp Nephrol. 2025 Feb;29(2):134-148. DOI: https://doi.org/10.1007/s10157-025-02624-9 PMid:39847311 PMCid:PMC11828805 DOI: https://doi.org/10.1007/s10157-025-02624-9

Xiao M, Wang X, Wang H, Du F, Yao Y, Wang X, Wang J, Yang J, Xiong W, Wang Q, Ren X, Zhu T. Risk factors for hyponatremia in acute exacerbation chronic obstructive pulmonary disease (AECOPD): a multicenter cross-sectional study. BMC Pulm Med. 2023 Jan 28;23(1):39. DOI: https://doi.org/10.1186/s12890-023-02328-4 PMid:36709254 PMCid:PMC9884134 DOI: https://doi.org/10.1186/s12890-023-02328-4

Lewis JL III. Hyponatremia. Retrieved 2025. Available from: https://www.msdmanuals.com/professional/endocrine-and-metabolic-disorders/electrolyte-disorders/hyponatremia

Al Mawed S, Pankratz VS, Chong K, Sandoval M, Roumelioti ME, Unruh M. Low serum sodium levels at hospital admission: Outcomes among 2.3 million hospitalized patients. PLoS One. 2018 Mar 22;13(3):e0194379. dDOI: https://doi.org/10.1371/journal.pone.0194379 PMid:29566068 PMCid:PMC5864034 DOI: https://doi.org/10.1371/journal.pone.0194379

Menteş O, Çelik D, Yildiz M, Kahraman A, Cirik MÖ, Eraslan Doğanay G, Ensarioğlu K, Babayiğit M, Kizilgöz D. Electrolyte Imbalance and Its Prognostic Impact on All-Cause Mortality in ICU Patients with Respiratory Failure. Medicina (Kaunas). 2025 Apr 1;61(4):642. DOI: https://doi.org/10.3390/medicina61040642 PMid:40282932 PMCid:PMC12028514 DOI: https://doi.org/10.3390/medicina61040642

Zinellu E, Fois AG, Sotgiu E, Mellino S, Mangoni AA, Carru C, Zinellu A, Pirina P. Serum Albumin Concentrations in Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. J Clin Med. 2021 Jan 13;10(2):269. DOI: https://doi.org/10.3390/jcm10020269 PMid:33450916 PMCid:PMC7828417 DOI: https://doi.org/10.3390/jcm10020269

Corona G, Giuliani C, Verbalis JG, Forti G, Maggi M, Peri A. Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis. PLoS One. 2015 Apr 23;10(4):e0124105. DOI: https://doi.org/10.1371/journal.pone.0124105. Erratum in: PLoS One. 2016 Mar 28;11(3):e0152846. DOI: https://doi.org/10.1371/journal.pone.0152846. PMid:25905459 PMCid:PMC4408113 DOI: https://doi.org/10.1371/journal.pone.0124105